Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24-26, 1997
edited by Fulvio Camerini, Antonello Gavazzi, Renata Maria.
Milano
Springer Milan
1998
(xv, 317 pages)
Introduction: II Florence Meeting on Advances in Cardiomyopathies --;The Classification of Cardiomyopathies --;Hypertrophic Cardiomyopathy --;The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy --;The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients --;The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients --;Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve --;Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy --;Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist's View --;The Clinicopathologic Spectrum of Hypertrophic Cardiomiopathy. The Experience of the Italian Heart Transplant Program --;Medical Treatment Options in Hypertrophic Cardiomyopathy --;DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art --;Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy --;Dilated Cardiomyopathy: Etiology, Pathophysiology and Clinical Data --;Genetic Basis of Dilated Cardiomyopathy --;Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances --;Organ-Specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications --;Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options --;Mitochondrial DNA Mutations and Cardiomyopathies --;Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy --;Myocardial Catecholamines and Inotropic Response in Heart Muscle Disease --;Molecular Biology of Heart Failure --;Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity? --;Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist? --;The Italian Multicentric Study: Natural History of Dilated Cardiomyopathy --;Mildly Dilated Cardiomyopathy --;Dilated Cardiomyopathy: Treatment --;Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis) --;Prevention of Sudden Death in Patients with Dilated Cardiomyopathy --;Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy --;Treatment of Dilated Cardiomyopathies with?-adrenergic Blocking Agents --;The role of?-Blockers in the Management of Heart Failure: Results of Controlled Trials --;Controversial Issues on?-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy? --?-Blockers for Heart Failure: Practical Issues --;DDD Pacing in Dilated Cardiomyopathy --;End-Stage Heart Failure and Timing of Heart Transplantation --;Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies --;Left Ventricular Assist Device as Bridge to Transplantation.
This book is a comprehensive and up-to-date overview on the ethiology, pathophysiology, clinical and therapeutic aspects of cardiomyopathies, edited by distinguished clinical researchers, who designed and followed a prospective natural history study on cardiomyopathies. Particular emphasis is given to clinical relevance of basic science advances in the field, from genetics to immunology. Controversial therapeutic issues are discussed. An eminently practical section is devoted to beta-blockade, the most novel medical treatment for heart failure. Non medical treatment options from pacing to cardiomyoplasty, artificial assist devices and transplantation are reviewed.
Cardiology.
Medicine.
Pathology.
RC685
.
D55
E358
1998
edited by Fulvio Camerini, Antonello Gavazzi, Renata Maria.